These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26182484)

  • 1. 2015 Annual Meeting of the Endocrine Society San Diego, CA (March 5-8, 2015) Selected Highlights.
    Hsu I; Burtman E; Ferris J; Austin J
    Pediatr Endocrinol Rev; 2015 Jun; 12(4):408-21. PubMed ID: 26182484
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral contraceptives in polycystic ovary syndrome.
    Helvaci N; Yildiz BO
    Minerva Endocrinol; 2014 Sep; 39(3):175-87. PubMed ID: 25003228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
    Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.
    Hillard PJ
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):707-23, x. PubMed ID: 16085167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation.
    Colonna L; Pacifico V; Lello S; Sorge R; Raskovic D; Primavera G
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1364-71. PubMed ID: 22011217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Treatment of Polycystic Ovary Syndrome.
    Huddleston HG; Dokras A
    JAMA; 2022 Jan; 327(3):274-275. PubMed ID: 35040896
    [No Abstract]   [Full Text] [Related]  

  • 7. Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits.
    Dokras A
    Fertil Steril; 2016 Dec; 106(7):1572-1579. PubMed ID: 27817838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLINICAL PRACTICE. Polycystic Ovary Syndrome.
    McCartney CR; Marshall JC
    N Engl J Med; 2016 Jul; 375(1):54-64. PubMed ID: 27406348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel strategies in the management of polycystic ovary syndrome.
    Spritzer PM; Motta AB; Sir-Petermann T; Diamanti-Kandarakis E
    Minerva Endocrinol; 2015 Sep; 40(3):195-212. PubMed ID: 25781065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent polycystic ovary syndrome.
    Connor EL
    Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in pediatric endocrinology.
    Kamboj MK
    Adolesc Med State Art Rev; 2013 Apr; 24(1):108-32, xii. PubMed ID: 23705521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
    De Leo V; Di Sabatino A; Musacchio MC; Morgante G; Scolaro V; Cianci A; Petraglia F
    Contraception; 2010 Sep; 82(3):276-80. PubMed ID: 20705157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of polycystic ovary syndrome in adolescence.
    Vitek W; Hoeger KM
    Semin Reprod Med; 2014 May; 32(3):214-21. PubMed ID: 24715516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome.
    Yao LQ; Kuang JQ; Feng YJ; Yang DZ; Li L; Xu CJ
    Fertil Steril; 2006 Mar; 85(3):805-8. PubMed ID: 16500371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
    Amiri M; Kabir A; Nahidi F; Shekofteh M; Ramezani Tehrani F
    Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):64-77. PubMed ID: 29457756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New diagnosis of polycystic ovary syndrome.
    McLuskie I; Newth A
    BMJ; 2017 Jan; 356():i6456. PubMed ID: 28082338
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the management of thyroid cancer and type 2 diabetes: highlights from the Annual Conference of the Society for Endocrinology (BES), March 15-18, 2010, Manchester, UK.
    Bandyopadhyay P
    Drugs Today (Barc); 2010 May; 46(5):361-7. PubMed ID: 20517537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meeting highlights: Endocrine Society, San Diego, California, June 19-22, 2010.
    Monzavi R; Kim M; Austin J; Vedin A; Franklin S
    Pediatr Endocrinol Rev; 2010 Dec; 8(2):114-22. PubMed ID: 21174899
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndromes of hyperandrogenism in women.
    Davis S
    Aust Fam Physician; 1999 May; 28(5):447-51. PubMed ID: 10376368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.